@TheKeatingFive
ROI have not paused the AZ vaccine for political reasons. It is a public health decision which I support. It is for a week. I am glad they are doing this, it makes me feel they are taking it seriously.
I'm sorry, but this is total rubbish. If it were for 'public health reasons' why haven't they also paused Pfizer, which has been responsible for more blood clotting events globally?
It absolutely was a political decision and a disgraceful one (speaking as an Irish person).
The efficacy for AZ and J&J are very similar (around 71%).
That's true only of mild disease. AZ is extremely efficacious in preventing moderate/severe disease - as good as Pfizer. That does not appear to be true of J&J.
The AZ vaccine has not been paused for political reasons. It is for public health.
Today the EMAwill meet and will look in detail at each of the four Norwegian cases. They will be looking to see if there were clots, how serious they were, and what type of clots they were. They will be asking if the rate of clotting is higher in those who have received an AstraZeneca vaccine than in the average population. They will also look at the data from AZ and will provide an independent review.
Prof McConkey said pausing the administration of AstraZeneca vaccines is the sign of a "cautious, well-run, prudent programme" and he thinks it is "reassuring" for people to see that we have a Government decision making system that is cautious and wants to see all the facts before proceeding.
I expect they will conclude that the benefits of vaccination outweigh the risk and will recommence with the AZ vaccine later this week.
Personally I would be happy to take either of these vaccines.
The AstraZeneca vaccine has been found to be 76% effective against the original coronavirus after the first dose. When a second dose is given 12 weeks or more after the first dose, the efficacy rises to 82%.
Data released by Johnson & Johnson suggest that 1 dose of vaccine was 66% effective in preventing moderate to severe COVID-19 and 100% effective in preventing COVID-19–related hospitalization and death.